Andrew Hykes - 12 Mar 2023 Form 4 Insider Report for Inari Medical, Inc.

Role: President and CEO, Director
Signature: /s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Issuer symbol: N/A
Transactions as of: 12 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Mar 2023, 19:08:05 UTC
Previous filing: 22 Feb 2023
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$0	+430,517	+330%	$0.000000	561,112	12 Mar 2023	Direct
holding	NARI	Common Stock						1,550	12 Mar 2023	By Child 1
holding	NARI	Common Stock						1,550	12 Mar 2023	By Child 2
holding	NARI	Common Stock						1,550	12 Mar 2023	By Child 3
holding	NARI	Common Stock						1,000	12 Mar 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Restricted Stock Unit	Options Exercise	$0	-430,517	-100%	$0.000000^*	0	12 Mar 2023	Common Stock	430,517	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied.